Your browser doesn't support javascript.
loading
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies.
Fargeot, Guillaume; Dupel-Pottier, Corinne; Stephant, Maeva; Lazarovici, Julien; Thomas, Laure; Mouthon-Reignier, Capucine; Riad, Benramdane; Carde, Patrice; Berzero, Giulia; Tafani, Camille; Nicolas, Weiss; Viala, Karine; Maisonobe, Thierry; Lenglet, Timothée; Wang, Adrien; Magy, Laurent; Bihan, Kevin; Gaspar, Nathalie; Adams, David; Echaniz-Laguna, Andoni; Cauquil, Cecile; Psimaras, Dimitri.
Afiliação
  • Fargeot G; Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France guillaume.fargeot@aphp.fr.
  • Dupel-Pottier C; Department of Neurology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
  • Stephant M; Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France.
  • Lazarovici J; Department of Hematology, Gustave Roussy Institute, Villejuif, France.
  • Thomas L; Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, France.
  • Mouthon-Reignier C; Department of Neurology, Centre Hospitalier Sud Francilien Site Gilles de Corbeil, Corbeil-Essonnes, France.
  • Riad B; Department of Hematology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
  • Carde P; Department of Hematology, Gustave Roussy institute, Paris-Saclay University, Villejuif, France.
  • Berzero G; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris, France.
  • Tafani C; Department of Neurology, Military Training Hospital Percy, Service de Santé des Armées, Paris, France, Military Health Service Academy of Val-de-Grâce, Service de Santé des Armées, Paris, France.
  • Nicolas W; Département de Neurologie, Unité de Médecine Intensive Réanimation neurologique, Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism
  • Viala K; Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
  • Maisonobe T; Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
  • Lenglet T; Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
  • Wang A; Department of Neurology, Foch Hospital, Suresnes, France.
  • Magy L; Department of Neurology, National Reference Center for Rare Peripheral Neuropathies, University Hospital, Limoges, France.
  • Bihan K; Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Gaspar N; Department of Pediatric and Adolescent Oncology, Gustave Roussy institute, Villejuif, France.
  • Adams D; Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France.
  • Echaniz-Laguna A; Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France.
  • Cauquil C; Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France.
  • Psimaras D; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris 75013, France, Paris, France.
J Neurol Neurosurg Psychiatry ; 91(7): 786-788, 2020 07.
Article em En | MEDLINE | ID: mdl-32327451
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Polirradiculoneuropatia Desmielinizante Inflamatória Crônica / Brentuximab Vedotin / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Polirradiculoneuropatia Desmielinizante Inflamatória Crônica / Brentuximab Vedotin / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article